Bionano Genomics (BNGO) Other Non Operating Income (2018 - 2026)

Bionano Genomics has disclosed Other Non Operating Income across 9 years of filings, most recently posting -$344000.0 for Q2 2026.

• In Q2 2026, Other Non Operating Income fell 150.89% year-over-year to -$344000.0; the TTM figure through Jun 2026 stood at -$820000.0 (up 75.52% YoY), while the FY2025 annual figure was $5.9 million, up 158.4% from the prior year.
• Other Non Operating Income came in at -$344000.0 for Q2 2026 at Bionano Genomics, up from -$619000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $5.1 million in Q1 2025 to a low of -$20.2 million in Q4 2023.
• Average Other Non Operating Income over 5 years is -$1.4 million, with a median of -$100500.0 recorded in 2022.
• Year-over-year, Other Non Operating Income tumbled 50307.5% in 2023 and surged 473.25% in 2025.
• Over 5 years, Other Non Operating Income stood at -$40000.0 in 2022, then plunged by 50307.5% to -$20.2 million in 2023, then surged by 58.3% to -$8.4 million in 2024, then soared by 104.31% to $362000.0 in 2025, then tumbled by 195.03% to -$344000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$344000.0 in Q2 2026, -$619000.0 in Q1 2026, and $362000.0 in Q4 2025.